Literature DB >> 24481598

Arm and trunk movement kinematics during seated reaching within and beyond arm's length in people with stroke: a validity study.

Ching-Yi Wu1, Rong-Jiuan Liing2, Hsieh-Ching Chen3, Chia-Ling Chen4, Keh-Chung Lin5.   

Abstract

BACKGROUND: Kinematic analysis is commonly used to objectively measure upper extremity movement performance after stroke. However, the concurrent validity and predictive validity of arm-trunk kinematics during reaching within and beyond arm's length have not been studied.
OBJECTIVE: The aim of this study was to estimate the concurrent validity of kinematic measures before and after treatment and the predictive validity for reaching within and beyond arm's length after stroke.
DESIGN: This was a secondary analysis study.
METHODS: Ninety-seven participants with stroke (mean age=55.9 years [SD=10.9]) received intensive treatment every weekday for 3 to 4 weeks. Kinematic reaching tasks and the Wolf Motor Function Test (WMFT) were used before and after treatment. The validity of the kinematic measures was estimated in relation to WMFT scores.
RESULTS: Of the 8 kinematic variables that were measured, index movement time before treatment (R2=.227-.362) and trunk movement time and trunk displacement after treatment (R2=.095-.346) had the strongest association with the WMFT at both reaching distances. Trunk movement time and trunk displacement before treatment explained 6.9% to 14.9% of the variance in the WMFT after treatment. Kinematic variables explained 6.9% to 49.3% and 9.4% to 38.7% of the variance in the WMFT during a task within arm's length and beyond arm's length, respectively. LIMITATIONS: The study has limited generalizability.
CONCLUSIONS: Different kinematic variables may partially reflect motor function before and after treatment to a limited degree. Although the predictive validity was modest, trunk movement may be considered a prognostic determinant of motor function after treatment. A reaching task within arm's length may be a more suitable measure of kinematic performance for describing motor function than a reaching task beyond arm's length.
© 2014 American Physical Therapy Association.

Entities:  

Mesh:

Year:  2014        PMID: 24481598     DOI: 10.2522/ptj.20130101

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  6 in total

1.  Does training with traditionally presented and virtually simulated tasks elicit differing changes in object interaction kinematics in persons with upper extremity hemiparesis?

Authors:  Gerard G Fluet; Alma S Merians; Qinyin Qiu; Maryam Rohafaza; Anita M VanWingerden; S V Adamovich
Journal:  Top Stroke Rehabil       Date:  2015-01-22       Impact factor: 2.119

2.  Video augmented mirror therapy for upper extremity rehabilitation after stroke: a randomized controlled trial.

Authors:  Hyunjin Kim; Junghyun Kim; Sungbae Jo; Kyeongjin Lee; Junesun Kim; Changho Song
Journal:  J Neurol       Date:  2022-10-10       Impact factor: 6.682

3.  Instrumental indices for upper limb function assessment in stroke patients: a validation study.

Authors:  Maria Longhi; Andrea Merlo; Paolo Prati; Meris Giacobbi; Davide Mazzoli
Journal:  J Neuroeng Rehabil       Date:  2016-06-08       Impact factor: 4.262

4.  Rehabilitation in progressive supranuclear palsy: Effectiveness of two multidisciplinary treatments.

Authors:  Ilaria Clerici; Davide Ferrazzoli; Roberto Maestri; Fabiola Bossio; Ilaria Zivi; Margherita Canesi; Gianni Pezzoli; Giuseppe Frazzitta
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

5.  End-point kinematics using virtual reality explaining upper limb impairment and activity capacity in stroke.

Authors:  Netha Hussain; Katharina S Sunnerhagen; Margit Alt Murphy
Journal:  J Neuroeng Rehabil       Date:  2019-07-01       Impact factor: 4.262

6.  Measures of Interjoint Coordination Post-stroke Across Different Upper Limb Movement Tasks.

Authors:  Anne Schwarz; Janne M Veerbeek; Jeremia P O Held; Jaap H Buurke; Andreas R Luft
Journal:  Front Bioeng Biotechnol       Date:  2021-01-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.